VALUE DISCOVERYS PROFILE ON BICO
VALUE DISCOVERIES PROFILES BICO
Bio-One Corporation is an emerging growth holding company in the nutritional supplements industry. Management is embarking on building a highly profitable $150 million revenue (Phase One) Company in the nutritional supplements industry via vertical integration of manufacturing facilities and industry consolidation of distribution companies.
The Company has targeted fifty-one Florida-based firms engaged in the manufacture and distribution of nutritional supplements as acquisition candidates. The Company has signed it's first Letter of Intent to acquire a $7 million manufacturing facility.
Bio-One Corp. (OTCBB: BICO) Check quotes at: BICO Quote
310 Waymont Ct. Ste. 100 Lake Mary, FL 32747
Stock Info Last Update July 30, 2001 4:00 PM Last Trade: July 30, Price: .61 52 Week Low: 0.05 High: .90
SHARES OUTSTANDING: 11 Mil SHARES IN THE FLOAT: 1.6 Mil
--------------------------------------------------------------------------------
INDUSTRY OUTLOOK
More than 100 million Americans are taking nutritional supplements; U.S. sales are approaching $60 billion annually; the industry has been, and is growing at a rate of 20% annually; it is highly fragmented with a majority of “first generation mom and pop” operations and is poised for consolidation. The Company’s domicile state, Florida, ranks second only to California in nutritional supplement sales and ranks first nationally in per capita consumption.
The Opportunity for the industry to be consolidated is exceptional. Many founders are reaching retirement age and with no exit strategy. The industry is highly fragmented with 90% of all companies revenues ranging from $500,000 to $5,000,000. More than 5,000 companies have revenues under $25 million. Bio-One has begun to consolidate from the bottom up.
LIVE BLOOD CELL ANALYSIS
The Company began providing its blood analysis test after May 30, 2000. However the principals have been working on the development for a number of years. The Company has designed and is providing a blood analysis test, which it has branded as its "Live Blood Cell Analysis” program. This blood work-up identifies the specific blood composition of individuals and attempts to identify, in the Company's opinion, a normal range and associated nutritional value after which it is able to tailor various naturopathic and nutritional supplement products to address specific conditions which have been identified by the test. The Company is utilizing its Live Blood Cell Analysis examination as a marketing approach by which it will be able to sell its full line of nutritional products. The Company's goal is to serve people worldwide who desire to live well as they live longer.
MANAGEMENT
The team possesses strong credentials and extensive industry experience, and has exhibited the proven performance, skills, and energy needed to build a high margin, low capital intensive national and international business. Specifically, our Management Team is a blend of senior executive leadership and junior executive leadership with over 70 years of industry experience, both nationally and internationally.
Frank Clark, Chairman of the Board of Directors has served as a former officer and director of several Fortune 500 health care companies. He was executive vice president and a director of a Johnson & Johnson subsidiary. He also has served as President and director of R.P. Scherer, Inc.
Armand Dauplaise, President & CEO, has extensive experience at the CEO and COO level spanning four industries. He has served in leadership positions with Hallmark Cards, the Burger King Corporation, Hardees, National Coffee Company, Coffee Butler Service, and Premier Services. Mr. Dauplaise has extensive experience in management, operations, marketing, mergers and acquisitions. He has received numerous industry awards for service, performance and leadership.
Bernard Shinder, Acting Chief Financial Officer and Director, has a long record of success in the practice of international law and finance. He has been engaged as a professional in most aspects of business finance including initial and secondary stock offerings, mergers, acquisitions, venture capital, international taxation strategy, international licensing, technology transfers, strategic planning and management of the expansion process. Mr. Shinder is well known as a developer of operational infrastructures and an expediter of the financial processes.
Kevin Thomas, Director and VitaRich President, founded the VitaRich Group to focus on the research, development, manufacturing and worldwide distribution of premium nutritional products. He previously worked as a biochemist, researcher, and product development director for two industry leaders. Mr. Thomas has written and has had published several of his articles and studies on the role of Pharmaceutical technology in the nutrition industry.
BOTTOM LINE
The Company believes there are four compelling reasons why anyone would want to invest in the successful future of Bio-One Corporation: 1) Management; 2) Industry; 3) Opportunity; 4) Plan. If you are one of the 100 million Americans who utilize nutritional supplements, appreciate the benefits and understand the "growing and graying market" opportunity at hand, you may wish to consider Bio-One Corporation as your way to capitalize on an a increasingly health-conscious society.
ORLANDO, FL, July 30, 2001/Business Wire - Bio-One Corporation - BICO - Stock Symbol Clarification
ORLANDO, FL, July 17, 2001/Business Wire - Bio-One Assembles New Management Team To Facilitate Future Growth
ORLANDO, FL, July 10, 2001/Business Wire - Bio-One Announces Letter of Intent to Acquire Leading Nutritional Supplement Manufacturer
ORLANDO, FL, June 29, 2001/Business Wire - Bio-One Corporation Announces Business Model
ADDITIONAL INFORMATION
To listen to Armand Dauplaise discuss the future of Bio-One Corp. go to MACREPORT.net and proceed to Company Profiles. A free registration may be required.
Robert Gartzman Public Relations: (561)447-7177
For the Value Discoveries newsletter: (240)465-7591
